During the testing of a therapeutic DNA vaccine encoding the TSA-1 antigen of T. cruzi in a murine model, the immunized mice exhibited significant increases in CD4 and CD8 T cells producing IFN-γ during the chronic phase of infection. The gene discussed is IFNG; the disease is infection.